Clinical trial
Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome
NCT00426543 · University of Copenhagen, Other · Completed
Key facts
| NCT number | NCT00426543 |
|---|---|
| Title | Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome |
| Official title | Phase 1 Study of B-cell Depletion With Rituximab on Oral, Ocular and General Disease Manifestations in Patients With Primary Sjögren's Syndrome |
| Lead sponsor | University of Copenhagen, Other |
| Collaborators | Rigshospitalet, Denmark |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Primary Sjögren's Syndrome, Xerostomia, Hyposalivation, Keratoconjunctivitis Sicca, Fatigue |
| Intervention type | Drug |
| Interventions | MabThera (rituximab), Rituximab, Mabthera |
| Enrollment | 21 |
| Start date | Jan 1, 2007 |
| Primary completion | Jun 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Jan 24, 2007 |
| Last update posted | Mar 14, 2017 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: